Cite Filings / ENTA / 0001172661-23-001232
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13G/A

Amended Statement of Ownership

ENANTA PHARMACEUTICALS INC · Filed 2023-02-14 · Acc 0001172661-23-001232

Documents 1

  • SC 13G/A Amended Statement of Ownership , firstmanhattan-enta123122a1.htm

Around this filing

  • 2023-10-06 SC 13G/A Amended Statement of Ownership
  • 2023-02-15 4 Sr. VP & General Counsel gave up 6,735 shares (to pay taxes)
  • 2023-02-15 4/A President and CEO gave up 20,591 shares (to pay taxes)
  • 2023-02-14 SC 13G/A Amended Statement of Ownership
  • 2023-02-14 SC 13G Amended Statement of Ownership
  • 2023-02-13 4 Treasurer and CFO sold 5,000 shares at an average $53.76 ($268,816)
  • 2023-02-09 SC 13G/A Amended Statement of Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · ADAR1 Capital Management, LLC 6.0%
  2. 2026-11-16 SCHEDULE 13G/A · Farallon Capital Management, L.L.C. 3.3%
Loading firstmanhattan-enta123122a1.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…